RE:Phase III will be a formalityAgreed Sir!
I think the focus is now very much on the future. That's great, finally. One more hurdle and I think shareholders reach the City of Gold finally on this one.
I have heard talk of the next trial possibly being cut short if the results are strong. Wouldn't it be amazing if we got an update on the results at 6 months - and found that the results mirrored Sustain and Assure in terms of MACE? A third trial showing the same thing would be very, very powerful evidence that we have a huge winner here.
So what's it worth if they show that??? That's the big question now. I'm sure management has a very good idea from all the talks this year with big pharma and other interested parties about valuation. I bet Dart knows exactly what the payoff will be....
I'm very curious to hear from management. The next Webcast (whenever that is) will be very interesting. Hopefully they can give us some idea of potential future valuation.... (although they might not to "go there" with us...)
If Re-Mace gives us the same Mace results and if they have solid autoimmune, metabolic and Azheimer's Data... what will the value of this formula be? One billion? Two billion? More?
Even if only the MACE data is there, it's still worth a lot of money. The other stuff/indications are icing.
Yes... the focus is again on the future. And it is looking very bright once again.